Minimization of olaratumab drug waste using real-world data.

  title={Minimization of olaratumab drug waste using real-world data.},
  author={Kristin M. Sheffield and Julie Kay Beyrer and Ian A. Watson and Kathleen Stafford and Bradley J Mills and Amine Ale-Ali},
  journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  volume={74 11},
PURPOSE Results of a study in which population-based body weight and body surface area (BSA) data were used for vial size optimization to reduce drug waste associated with administration of the i.v. anticancer agent olaratumab are reported. METHODS A retrospective observational study was conducted to determine weight and BSA distributions in a large sample of U.S. oncology patients using data from a large electronic medical record database. Body weight and BSA values at the time of initial… CONTINUE READING


Publications citing this paper.


Publications referenced by this paper.
Showing 1-10 of 22 references

Lartruvo (olaratumab) prescribing information

  • Eli Lilly, Company
  • 2017
1 Excerpt

Lartruvo ( olaratumab ) prescribing information lowable excess volume and labeled vial fill size in injectable drug and biological products : guidance for industry

  • N Ibrahim
  • 2015

Variations in body surface area of patients receiving chemotherapy treatment in England. view?rid=2293

  • M. Wallington
  • 2015
1 Excerpt

Similar Papers

Loading similar papers…